Advertisement

Topics

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Company Profile

10:03 EDT 25th June 2018 | BioPortfolio


News Articles [4553 Associated News Articles listed on BioPortfolio]

Divide and conquer: Israeli researchers find key to creating better medicines with fewer side effects

(The Hebrew University of Jerusalem) A new study published in Science by professors Yossi Paltiel of the Hebrew University of Jerusalem and Ron Naaman from the Weizmann Institute of Science describes ...

Prolonged acetaminophen use during pregnancy linked to increased ASD and ADHD risk

(The Hebrew University of Jerusalem) Acetaminophen is one of the most common medications used for treatment of pain and fever reduction during pregnancy and is considered safe in humans. Now, in a fir...

Scientists generate an atlas of the human genome using stem cells

(The Hebrew University of Jerusalem) Scientists from the Hebrew University of Jerusalem have generated an atlas of the human genome that illuminates the roles our genes play in health and disease. Th...

Merck opens Jerusalem innovation lab

The laboratory is part of Merck’s commitment to Israel, collaboration with the Hebrew University, and development efforts in nanotechnologies and materials.

A leopard may not change its spots but venomous creatures change their venom recipe often

(The Hebrew University of Jerusalem) For a long time scientists believed that an animal's venom was consistent over time. However, through a close study of sea anemones, Dr. Yehu Moran of Hebrew Unive...

Centogene Publishes Study Identifying the Best Biomarker for Monitoring Response to Therapy for Patients with Gaucher Disease

ROSTOCK, Germany–(BUSINESS WIRE)–CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, announced the publication of a s...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 19032018] Prices from USD $250

SummaryYissum Research Development Company of the Hebrew University of Jerusalem Ltd YRDC is a technology transfer company that offers marketing the inventions and knowhow generated by the University'...

Smaller and faster: The terahertz computer chip is now within reach

Following three years of extensive research, Hebrew University of Jerusalem (HU) physicist Dr. Uriel Levy and his team have created technology that will enable our computers–and all o

PubMed Articles [3439 Associated PubMed Articles listed on BioPortfolio]

THE NEW HADASSAH-HEBREW UNIVERSITY MEDICAL CENTER: A LEADER IN ISRAELI PUBLIC MEDICINE.

Hadassah-Hebrew University Medical Center is regaining its lead in Israeli public medicine with clinical excellence, state-of-the art technology, high achievement in research, and outstanding medical ...

ADVANCES IN THE TREATMENT OF RETINOBLASTOMA AT HADASSAH IN THE LAST THREE DECADES.

Retinoblastoma (RB) is a malignant tumor presenting in the eyes of infants and children, which endangers life, the eye and vision. The treatment of RB has undergone marked changes in recent years, and...

Validation of the Hebrew Version of the Eating Assessment Tool-10 (H-EAT-10).

Dysphagia is a common disability with different etiologies. In order to measure dysphagia symptom severity and effects on quality of life, the Eating Assessment Tool (EAT-10) was developed and validat...

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Henry Herbert Donaldson's (1857-1938) contribution to an organized approach to the experimental study of the mammalian central nervous system.

This article shows that the academic and research careers of Henry Herbert Donaldson (1857-1938) were directed to provide basic information about the growth of the vertebrate nervous system and to pro...

Clinical Trials [4876 Associated Clinical Trials listed on BioPortfolio]

Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease

The research is aimed at exploring the application of novel tracking technique for the study of spatial activity among dementia patients and its implication on their families. The study sa...

The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control

The purpose of this randomized, double-blind, placebo-controlled study was to determine whether jerusalem artichoke and fermented soybeans powder mixture is effective in the control of blo...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

The Development of Younger Siblings of Children With Autism Now at 10 Years of Age

Background: Autism is a complex developmental disorder involving difficulties in verbal and nonverbal communication, social-emotional functioning, and markedly restricted interests and act...

Follow-up Study on Recipients of Treatment at the Jerusalem Center for the Treatment of Psychotrauma

Researchers examined perceived satisfaction and perceived increase or decrease in symptoms among recipients of treatment at the Jerusalem Center for the Treatment of Psychotrauma, using se...

Companies [6724 Associated Companies listed on BioPortfolio]

Yissum Ltd.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. was founded in 1964 to protect and commercialize the Hebrew University’s intellectual property....

Yissum Research Development Company of the Hebrew University of Jerusalem

Yissum, the Technology Transfer Company (TTC) is responsible for recognizing and managing the intellectual property assets of the Hebrew University in Jerusalem.A researcher presenting an innovative b...

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

American Friends of The Hebrew University

The Hebrew University of Jerusalem, located on three campuses in Jerusalem and a fourth in Rehovot, is among the top 100 academic and research institutions worldwide. Approximately 23,000 students fr...

Avraham Pharmaceuticals Ltd.

Founded in 2010, Avraham Pharmaceuticals has raised more than $12 million to advance the development of its unique, multi-functional drug substance, ladostigil, currently undergoi...

More Information about "Yissum Research Development Company of the Hebrew University of Jerusalem Ltd." on BioPortfolio

We have published hundreds of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. news stories on BioPortfolio along with dozens of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Clinical Trials and PubMed Articles about Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Companies in our database. You can also find out about relevant Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record